AGC Completes Acquisition of Spanish Synthetic Pharmaceutical Active Ingredient Manufacturer Malgrat Pharma Chemicals

March 04, 2019   |   March 2019 Bond Updates
TOKYO, March 4, 2019 /PRNewswire/ -- AGC Inc. based in Tokyo announced on March 4 the completion of its acquisition of Spain's synthetic pharmaceutical active ingredient manufacturer, Malgrat Pharma Chemicals, S.L.U. (hereinafter referred to as MPC). The transaction had been previously...

View more at:
Related News
Home| About us | Contact us